North Star Investment Management’s Purple Biotech PPBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2
Closed -$9 1608
2025
Q3
$9 Hold
2
﹤0.01% 1318
2025
Q2
$35 Hold
2
﹤0.01% 1203
2025
Q1
$40 Hold
2
﹤0.01% 1189
2024
Q4
$70 Hold
2
﹤0.01% 1202
2024
Q3
$83 Hold
2
﹤0.01% 1166
2024
Q2
$122 Hold
2
﹤0.01% 1140
2024
Q1
$201 Hold
2
﹤0.01% 1204
2023
Q4
$234 Hold
2
﹤0.01% 1155
2023
Q3
$357 Hold
2
﹤0.01% 1221
2023
Q2
$418 Hold
2
﹤0.01% 1228
2023
Q1
$537 Hold
2
﹤0.01% 1233
2022
Q4
$414 Hold
2
﹤0.01% 1248
2022
Q3
$1K Hold
2
﹤0.01% 1093
2022
Q2
$1K Hold
2
﹤0.01% 1098
2022
Q1
$1K Hold
2
﹤0.01% 1114
2021
Q4
$1K Hold
2
﹤0.01% 1142
2021
Q3
$1K Hold
2
﹤0.01% 1089
2021
Q2
$1K Hold
2
﹤0.01% 1063
2021
Q1
$1K Hold
2
﹤0.01% 1026
2020
Q4
$1K Hold
2
﹤0.01% 1001
2020
Q3
$1K Buy
+2
New +$2.47K ﹤0.01% 982

Other funds holding PPBT

North Star Investment Management's PPBT Position: Q4 2025 in Review

North Star Investment Management sold out of Purple Biotech (PPBT) in Q4 2025, closing a stake of 2 shares — an estimated $9 sold.

North Star Investment Management first reported a position in PPBT in Q3 2020 and held it in 21 quarters. The position peaked at $1K in Q3 2022. 19 funds tracked by Wall St. Rank hold PPBT as of Q4 2025.

  • North Star Investment Management reported no remaining Purple Biotech position as of Q4 2025 after selling out during the quarter.
  • North Star Investment Management sold 2 Purple Biotech shares in Q4 2025, an estimated $9.
  • North Star Investment Management first reported a position in Purple Biotech in Q3 2020 and held it in 21 quarters.
  • North Star Investment Management's Purple Biotech position peaked at $1K in Q3 2022.
  • 19 funds tracked by Wall St. Rank held Purple Biotech as of Q4 2025.

Based on North Star Investment Management's 13F filing for Q4 2025, filed 30 Jan 2026.